Recruiting Leukemia Studies in Madrid
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
This pivotal phase 2/3, multi-center, adaptive design study of L-Annamycin for Injection in combination with Cytarabine Injection as second line therapy for remission induction in adult subjects with ...
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
A Phase 1/2a study to assess the safety, tolerability, PK and biological activity of CCS1477 (inobrodib) in patients with Non-Hodgkin Lymphoma, Multiple Myeloma, Acute Myeloid Leukaemia or High Risk M...
About Leukemia Clinical Trials in Madrid
Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.
There are currently 2 leukemia clinical trials recruiting participants in Madrid, . These studies are seeking a combined 562 participants. Research is being sponsored by Moleculin Biotech, Inc., CellCentric Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Leukemia Clinical Trials in Madrid — FAQ
Are there leukemia clinical trials in Madrid?
Yes, there are 2 leukemia clinical trials currently recruiting in Madrid, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Madrid?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Madrid research site will contact you about next steps.
Are clinical trials in Madrid free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Madrid studies also compensate for your time and travel.
What leukemia treatments are being tested?
The 2 active trials in Madrid are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.
Data updated March 2, 2026 from ClinicalTrials.gov